Skip to main content
Fig. 3 | World Journal of Surgical Oncology

Fig. 3

From: Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

Fig. 3

The summary of odds ratios of pCR, TRG, T downstaging, and N downstaging between DM patients with metformin (DM + /MF +) and DM patients without metformin (DM + /MF −). Oh (2016) has two cohorts: Oh 2016 (neoadjuvant CRT followed by surgical resection from 2007 to 2011) and Oh 2016’ (neoadjuvant CRT followed by surgical resection from 2012 to 2014)

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us